Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

<< Back to News

3/17/23 sh B&O (belladonna and opium) Suppository - Manufacturer Discontinuation
March 20, 2023

From: "Steven Higginbotham" <steven.higginbotham@hhsys.org>
To: "Pharmacy Department" <grp_pharmacy@hhsys.org>
Sent: Friday, March 17, 2023 4:00:01 PM
Subject: B&O (belladonna and opium) Suppository - Manufacturer Discontinuation
 
The information below has been sent out the the medical staff.



B&O (belladonna and opium) suppositories have been discontinued by the sole manufacturer and are no longer available to purchase. As a result, B&O suppositories will no longer be available for use beginning 4/5/2023.

Suggested alternatives for ureteral/bladder spasms are listed below:
 
MEDICATION ROUTE DOSE
hyoscyamine Oral 0.25 mg q 6hrs PRN
oxybutynin Oral 5 mg q 6hrs PRN
phenazopyridine Oral 200 mg three times daily PRN
tamsulosin Oral 0.4 mg once daily
tolterodine Oral 2 mg twice daily
 
Please contact your pharmacist if you have any questions.






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved